Lexicon Pharmaceuticals, Inc. |
47.74 |
Scholar Rock Holding Corporation |
14.46 |
GlycoMimetics, Inc. |
13.34 |
Silence Therapeutics plc |
10.02 |
Syros Pharmaceuticals, Inc. |
9.47 |
IGM Biosciences, Inc. |
9.31 |
Seer, Inc. |
7.82 |
Harpoon Therapeutics, Inc. |
7.7 |
Selecta Biosciences, Inc. |
5.89 |
HOOKIPA Pharma Inc. |
5.87 |
AlloVir, Inc. |
5.74 |
Achilles Therapeutics plc |
5.53 |
SQZ Biotechnologies Company |
5.45 |
Gossamer Bio |
5.35 |
Cyclerion Therapeutics, Inc. |
5.13 |
Vigil Neuroscience, Inc. |
4.91 |
Morphic Holding, Inc. |
4.27 |
Generation Bio Co. |
4.23 |
Kymera Therapeutics, Inc. |
4.14 |
Black Diamond Therapeutics, Inc. |
3.96 |
Ovid Therapeutics Inc. |
3.54 |
Vor Biopharma Inc. |
3.44 |
Selecta Biosciences, Inc. |
3.18 |
Erasca, Inc. |
3.12 |
ACELYRIN, INC. Common Stock |
3.09 |
Sagimet Biosciences Inc. Series A Common Stock |
3.04 |
Solid Biosciences Inc. |
2.41 |
Omega Therapeutics, Inc. |
2.4 |
Adagene Inc. |
2.27 |
Lexeo Therapeutics, Inc. |
2.26 |
Talaris Therapeutics, Inc. |
2.17 |
Ikena Oncology, Inc. |
2.07 |
Wave Life Sciences Ltd. |
2.02 |
Taysha Gene Therapies, Inc. |
1.96 |
TCR2 Therapeutics Inc. |
1.91 |
Repare Therapeutics Inc. |
1.89 |
Curis, Inc. |
1.78 |
Foghorn Therapeutics Inc. |
1.69 |
Neumora Therapeutics, Inc. Common Stock |
1.61 |
Xilio Therapeutics, Inc. |
1.31 |
ContraFect Corporation |
0.51 |
Tourmaline Bio, Inc. |
0.36 |
Senti Biosciences, Inc. |
0.12 |